Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age.

Literature DB >> 22143833

Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age.

Bart C J M Fauser, Philippe Bouchard.

Abstract

Entities: Disease Species

Mesh：

Year: 2011 PMID： 22143833 DOI： 10.1210/jc.2011-2935

Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN： 0021-972X Impact factor: 5.958

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Further delineation of familial polycystic ovary syndrome (PCOS) via whole-exome sequencing: PCOS-related rare FBN3 and FN1 gene variants are identified.

Authors: Cengiz Karakaya; Aylin Pelin Çil; Kaya Bilguvar; Tunahan Çakir; Mete Hakan Karalok; Recep Onur Karabacak; Ahmet Okay Caglayan
Journal: J Obstet Gynaecol Res Date: 2022-02-09 Impact factor: 1.697

2. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.

Authors: D Glintborg; A P Hermann; L M Rasmussen; M Andersen
Journal: J Endocrinol Invest Date: 2012-11-26 Impact factor: 4.256

3. Cardiometabolic Effects of Chronic Hyperandrogenemia in a New Model of Postmenopausal Polycystic Ovary Syndrome.

Authors: Carolina Dalmasso; Rodrigo Maranon; Chetan Patil; Elizabeth Bui; Mohadetheh Moulana; Howei Zhang; Andrew Smith; Licy L Yanes Cardozo; Jane F Reckelhoff
Journal: Endocrinology Date: 2016-05-04 Impact factor: 4.736

4. Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes. A Preliminar Case-Control Study.

Authors: María L Sánchez-Ferrer; Ernesto De La Cruz-Sánchez; Julián J Arense-Gonzalo; María T Prieto-Sánchez; Itziar Bernabeu-González; Ana Carmona-Barnosi; Jaime Mendiola; Alberto M Torres-Cantero
Journal: Int J Environ Res Public Health Date: 2021-03-14 Impact factor: 3.390

5. Association between fasting blood glucose and carotid intima-media thickness of polycystic ovary syndrome patients with normal glucose tolerance.

Authors: Kuk Hui Son; Nam Kyoo Lim; Hye Won Chung; Kyungah Jeong; Wook Bum Pyun; Ji Young Lee; Min Ju Kim; Hyun-Young Park
Journal: Diabetes Care Date: 2013-05 Impact factor: 19.112

Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age.

1. Further delineation of familial polycystic ovary syndrome (PCOS) via whole-exome sequencing: PCOS-related rare FBN3 and FN1 gene variants are identified.

2. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.

3. Cardiometabolic Effects of Chronic Hyperandrogenemia in a New Model of Postmenopausal Polycystic Ovary Syndrome.

4. Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes. A Preliminar Case-Control Study.

5. Association between fasting blood glucose and carotid intima-media thickness of polycystic ovary syndrome patients with normal glucose tolerance.

Review 6. Polycystic ovary syndrome: clinical implication in perimenopause.

7. Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study.

8. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles.